Premium
Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia
Author(s) -
Palacios José M.,
Chinaglia Giorgia,
Rigo Monique,
Ulrich Jürg,
Probst Alphonse
Publication year - 1991
Publication title -
synapse
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.809
H-Index - 106
eISSN - 1098-2396
pISSN - 0887-4476
DOI - 10.1002/syn.890070205
Subject(s) - globus pallidus , neurotensin , substantia nigra , pars compacta , basal ganglia , nucleus accumbens , neurotensin receptor , medicine , caudate nucleus , endocrinology , putamen , pars reticulata , 5 ht4 receptor , biology , chemistry , neuroscience , receptor , neuropeptide , dopamine , dopaminergic , central nervous system , agonist
Autoradiographic techinques were used to examine the distribution and levels of neurotensin receptor binding sites in the basal gangila and related regions of the human brain. Monoido ([ 125 I]‐Tyr 3 )neurotensin was used as a ligand. High amounts of neurotensin receptor binding sites were found in the substantia nigra pars compacta. Lower but significant quantities of neurotensin receptor binding sites characterized the caudate, putamen, and nucleus accumbens, while very low quantities were seen in both medial and lateral segments of the globus pallidus. In Huntington's chorea, the levels of neurotensin receptor binding sites were found to be comparable to those of control cases. Only slight but not statistically significant decreases in amounts of receptor binding sites were detected in the dorsal part of the head and in the body of caudate nucleus. No alterations in the levels of neurotensin receptor bindingsites were observed in the substantia nigra pars compacta and reticulata. These results suggest that a large proportion of neurotensin receptoe binding sites in the basal ganglia are located on intrinsic neurons and on extrinsic afferent fibers that do not degenerate in Huntington's disease.